Europe To Review Blood Clot Risks In Contraceptives
The European Medicines Agency on Monday announced that it will review the risks associated with third- and fourth-generation combined oral contraceptives, such as Yaz, after French regulators raised concerns that the...To view the full article, register now.
Already a subscriber? Click here to view full article